And the treatment of EGCG in non-small cell lung cancer (NSCLC) cells stimulates the sensitivity of NSCLC cells to chemotherapy drugs by increasing lncRNA NEAT1 expression [27]. The gene discussed is NEAT1; the disease is non-small cell lung carcinoma.